Adrenocortical Carcinoma (ACC)
Oncology·MeSH: Adrenocortical Carcinoma
Prevalence
0.5 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Adrenocortical Carcinoma (ACC)?
There are 1 clinical trial targeting Adrenocortical Carcinoma (ACC) tracked by BioSniper.
What is the prevalence of Adrenocortical Carcinoma (ACC)?
The estimated prevalence of Adrenocortical Carcinoma (ACC) is approximately 0.5 per 100,000 population.
Deep-dive into Adrenocortical Carcinoma (ACC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis